JS Link Inc, formerly DNA Link Inc, is a Korea-based company mainly engaged in the genome analysis business. The Company mainly engages in the research and development of genome analysis services and personal genome analysis service products used for disease prevention, diagnosis, and treatment. The Company also mainly engages in the manufacture and sale of coronavirus disease 2019 (COVID-19) diagnostic kits. In addition, the Company engages in the research and development of â€˜Avatar Mouse,â€™ an anticancer drug efficacy evaluation system using the mouseâ€™s biological system.

Employees

147

Sector

Biotechnology & Medical Research

More about the company

Quotes

Date	Price	Change	Volume
07/26/07	₩27,850.00	-7.01%	1,73,364
06/26/06	₩29,950.00	+2.57%	1,63,636
02/26/02	₩29,200.00	-3.79%	1,66,864
01/26/01	₩30,350.00	-0.33%	1,00,533
30/26/30	₩30,450.00	+2.53%	1,19,651

End-of-day quote Korea S.E.

More quotes

End-of-day quote Korea S.E. 06/10/2026			5-day change	1st Jan Change
29,950.00 ^KRW	+2.57%		+0.84%	+67.79%

21/09	JS Link, Inc.(KOSDAQ:A127120) added to S&P Global BMI Index	CI
14/08	JS Link, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

Market Cap	97TCr 72Cr 65Cr 60Cr 55Cr 103.03Cr 6.99TCr 103.8Cr 723.74Cr 282.75Cr 3.55TCr 271.24Cr 265.37Cr 11TCr	P/E 2024	-10.5x	P/E 2025	-29.7x
Enterprise Value	97TCr 72Cr 65Cr 60Cr 55Cr 103.34Cr 7.01TCr 104.11Cr 725.9Cr 283.59Cr 3.56TCr 272.04Cr 266.16Cr 11TCr	EV / Sales 2024	8.93x	EV / Sales 2025	29.6x
Free-Float	72.57%	Yield 2024 *	-	Yield 2025	-

21/09	JS Link, Inc.(KOSDAQ:A127120) added to S&P Global BMI Index	CI
14/08	JS Link, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
29/07	JS Link, Inc. announced that it has received KRW 53.392992 billion in funding from Lynas Rare Earths Limited	CI
07/07	REalloys Inc. and JS Link Inc. Sign Non-Binding Strategic Letter of Intent to Develop Fully Integrated North American Rare Earth Magnet Platform	CI
07/07	Australia's Lynas, South Korea's JS Link sign deal for Malaysia magnet factory	RE
07/07	Australia's Lynas signs deal with South Korea's JS Link to develop Malaysian magnet factory	RE
25/06	JS Link, Inc. announced that it has received KRW 30 billion in funding from Joosung Sea & Air Co. Ltd	CI
15/05	JS Link, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
13/05	JS Link, Inc. announced that it expects to receive KRW 5 billion in funding	CI
13/05	JS Link, Inc. announced that it expects to receive KRW 30 billion in funding	CI
23/03	JS Link, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03/02	JS Link, Inc. announced that it has received KRW 20.00000805 billion in funding from Orbitech Co., Ltd., Joosung Sea & Air Co. Ltd	CI
14/11	JS Link, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI

1 day	+2.57%
1 week	+0.84%
Current month	-1.64%
1 month	-10.86%
3 months	-18.83%
6 months	-26.05%
Current year	+67.79%

JS Link, Inc. Share Price

Stocks

A127120

KR7127120004

Biotechnology & Medical Research

Valuation: JS Link, Inc.

Chart: JS Link, Inc.

Latest news: JS Link, Inc.

Press Releases: JS Link, Inc.

Quotes and Performance

Price Extremes

Managers and Directors: JS Link, Inc.

Latest insider transactions

Other Biotechnology & Medical Research

Financials

Company Profile

Quotes

1 week	28,800	30,750
1 month	28,800	34,850
Current year	16,230	49,900
1 year	13,860	49,900
3 years	1,775	49,900
5 years	1,775	49,900
10 years	1,775	49,900

Manager	Title	Age	Since
Jun-Young Lee CEO	Chief Executive Officer	58	23/08/2024
Cheol-Gu Sim CEO	Chief Executive Officer	47	20/10/2023
Kenji Gonishi PRN	Corporate Officer/Principal	58	23/08/2024

Director	Title	Age	Since
Cheol-Gu Sim BRD	Director/Board Member	47	20/10/2023
Jun-Young Lee BRD	Director/Board Member	58	23/08/2024
Kenji Gonishi BRD	Director/Board Member	58	23/08/2024

Date	Insider	Type	Quantity	% Market Cap.
19/11/25	Jin-soo Park	Buy	1,500	0.0047%
17/11/25	Jin-soo Park	Buy	5,000	0.0157%
04/11/25	Jin-soo Park	Buy	87,138	0.2742%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
JS LINK, INC.	+2.57%	+0.84%	+43.65%	+713.86%	78Cr
WUXI APPTEC CO., LTD.	+4.16%	+4.16%	+49.37%	+94.17%	7.47TCr
ARGENX SE	+0.46%	-0.97%	+23.51%	+79.34%	5.88TCr
LONZA GROUP AG	+0.17%	-1.16%	+3.59%	+34.55%	4.84TCr
REVOLUTION MEDICINES, INC.	+0.50%	-2.14%	+331.33%	+702.20%	4.28TCr
IQVIA HOLDINGS INC.	-0.72%	-3.99%	+28.50%	+29.94%	4.28TCr
BEONE MEDICINES AG	+0.34%	-0.52%	+6.56%	+109.35%	4.12TCr
CELLTRION, INC.	-0.11%	+1.96%	+9.19%	+52.66%	3.11TCr
WUXI BIOLOGICS (CAYMAN) INC.	-2.07%	+1.16%	+35.00%	+26.28%	3.03TCr
BIONTECH SE	-0.50%	-3.10%	-10.19%	-14.35%	2.4TCr
Average	+0.48%	+0.53%	+52.05%	+182.80%	3.95TCr
Weighted average by Cap.	+0.69%	+0.18%	+55.85%	+131.35%

	2024	2025
Net sales	1.59TCr 1.19Cr 1.06Cr 98.99L 89.91L 1.69Cr 114.87Cr 1.71Cr 12Cr 4.65Cr 58Cr 4.46Cr 4.36Cr 187.8Cr	1.93TCr 1.44Cr 1.29Cr 1.2Cr 1.09Cr 2.06Cr 139.48Cr 2.07Cr 14Cr 5.64Cr 71Cr 5.41Cr 5.3Cr 228.05Cr
Net income	-1.08TCr -80.63L -72.04L -67.22L -61.05L -1.15Cr -78Cr -1.16Cr -8.08Cr -3.16Cr -40Cr -3.03Cr -2.96Cr -127.52Cr	-1.64TCr -1.23Cr -1.1Cr -1.02Cr -92.95L -1.75Cr -118.75Cr -1.76Cr -12Cr -4.8Cr -60Cr -4.61Cr -4.51Cr -194.15Cr
Net Debt	1.44TCr 1.07Cr 95.99L 89.56L 81.35L 1.53Cr 103.93Cr 1.54Cr 11Cr 4.2Cr 53Cr 4.03Cr 3.95Cr 169.91Cr	288.15Cr 21.51L 19.22L 17.93L 16.29L 30.67L 21Cr 30.9L 2.15Cr 84.18L 11Cr 80.75L 79L 34Cr